TY - JOUR
T1 - Short report
T2 - Absence of an association between Plasmodium falciparum infection and post-ivermectin Loa-related non-neurologic serious adverse events
AU - Fokom-Domgue, Joël
AU - Pion, Sébastien D.
AU - Gounoue, Raceline
AU - Akame, Julie
AU - Nguipdop-Djomo, Patrick
AU - Twum-Danso, Nana A.Y.
AU - Thylefors, Björn
AU - Boussinesq, Michel
AU - Kamgno, Joseph
PY - 2014/2
Y1 - 2014/2
N2 - Although ivermectin treatment can induce serious adverse events (SAEs) in individuals harboring high Loa loa microfilaremia (mf), not all patients with high mf levels develop such reactions, suggesting that cofactors may be involved. A study was conducted in Cameroon to investigate the possible role of Plasmodium coinfection at the time of ivermectin treatment in the development of SAEs. Before their first ivermectin treatment, thick smears were obtained from 4,175 individuals to determine the burden of Plasmodium sp., L. loa, and Mansonella perstans. After treatment, 18 (4.3 per 1,000) patients developed a non-neurologic SAE. Logistic regression analysis, adjusting for age, sex, P. falciparum infection, and M. perstans infection intensities, confirmed that L. loa mf was the main risk factor for SAEs. We found no evidence that coinfection with P. falciparum at the time of ivermectin treatment was associated with the occurrence of Loa-related SAEs in this population.
AB - Although ivermectin treatment can induce serious adverse events (SAEs) in individuals harboring high Loa loa microfilaremia (mf), not all patients with high mf levels develop such reactions, suggesting that cofactors may be involved. A study was conducted in Cameroon to investigate the possible role of Plasmodium coinfection at the time of ivermectin treatment in the development of SAEs. Before their first ivermectin treatment, thick smears were obtained from 4,175 individuals to determine the burden of Plasmodium sp., L. loa, and Mansonella perstans. After treatment, 18 (4.3 per 1,000) patients developed a non-neurologic SAE. Logistic regression analysis, adjusting for age, sex, P. falciparum infection, and M. perstans infection intensities, confirmed that L. loa mf was the main risk factor for SAEs. We found no evidence that coinfection with P. falciparum at the time of ivermectin treatment was associated with the occurrence of Loa-related SAEs in this population.
UR - http://www.scopus.com/inward/record.url?scp=84893459511&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84893459511&partnerID=8YFLogxK
U2 - 10.4269/ajtmh.13-0189
DO - 10.4269/ajtmh.13-0189
M3 - Article
C2 - 24420781
AN - SCOPUS:84893459511
SN - 0002-9637
VL - 90
SP - 335
EP - 338
JO - American Journal of Tropical Medicine and Hygiene
JF - American Journal of Tropical Medicine and Hygiene
IS - 2
ER -